Inventor · disambiguated record
Seng-Lai Tan
Also filed as: TAN SENG-LAI
6 granted patents·13 pending applications·17 citations·filing 2013–2025
79Inventor score
Files withMARENGO THERAPEUTICS INC15BICARA THERAPEUTICS INC2FORMA THERAPEUTICS INC1HOFFMANN LA ROCHE1
Top patents by PatentIndex Score
19 records- 0195US11965025B2Method of treating solid cancers with bispecific interleukin-anti-TCRß moleculesMARENGO THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·7 cites·26 claims
- 0293US11845797B2Anti-TCR antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2019·Granted Dec 19, 2023·7 cites·34 claims
- 0392US12351632B2Anti-TCR antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2023·Granted Jul 8, 2025·1 cites·33 claims
- 0491US12486326B2Anti-TCR antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2023·Granted Dec 2, 2025·1 cites·10 claims
- 0591US12286477B2Anti-TCR antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2022·Granted Apr 29, 2025·1 cites·29 claims
- 0686US2024301060A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0782US2025340640A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0878US2025215085A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0977US2022064297A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1070US2023227552A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1163US2019374536A1Methods of using fasn inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1263US2025333500A1Multifunctional molecules that bind to t cell related cancer cells and uses thereofMARENGO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1361US12358982B2Multifunctional molecules that bind to T cell related cancer cells and uses thereofMARENGO THERAPEUTICS INC·Filed 2021·Granted Jul 15, 2025·0 cites·23 claims
- 1459US2021380692A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1553US2024392031A1Caix targeting il-12 fusion proteins and methods of use thereofBICARA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1652US2021380670A1Multifunctional molecules that bind to calreticulin and uses thereofMARENGO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1751US2021380691A1Multifunctional molecules that bind to t cells and uses thereof to treat autoimmune disordersMARENGO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1849US2024228620A1Multispecific proteins and related methodsBICARA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1939US2016009772A1Cell penetrating peptides which bind irf5HOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Seng-Lai Tan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →